Saudi healthtech startup Madeed has secured additional pre-seed funding, bringing its total capital raised to $925,000. The company is building a platform focused on proactive disease prevention through advanced laboratory data and artificial intelligence.
Quick Facts
- Total Funding: $925,000 Pre-Seed.
- Mission: Early disease risk detection via biomarkers and AI.
- Key Investors: SEEDRA Ventures, Unity Investment Partners, Vision Ventures.
- Market Focus: Initial expansion in Saudi Arabia.
A Proactive Approach to Health
Madeed is positioning itself as one of the first platforms in the Middle East dedicated to personalised preventive healthcare and longevity. The company moves away from traditional reactive treatment by using advanced lab data and AI to spot early risk indicators for hundreds of diseases before symptoms emerge.
The platform provides users with personalised health recommendations and develops custom health plans and nutritional supplements tailored to individual needs and lifestyles. This data-driven model attracted 150 subscribers during its pilot phase, signaling strong market interest.
“We dedicated the past period to conducting the necessary operational tests on the platform to ensure its efficiency, smooth operation, and the integration of the services offered,” said Dr. Adam Batayneh, founder and CEO of Madeed. “We are optimistic about the results achieved so far, having attracted 150 subscribers during the pilot phase, which we consider a clear indicator of the expected demand upon the official launch.”
Investor Backing and Strategic Growth
This latest funding infusion came from SEEDRA Ventures, a Riyadh-based VC firm backing local entrepreneurs, alongside Unity Investment Partners and Seen Growth. They join an earlier group of investors led by Vision Ventures, which contributed to an initial $400,000 pre-seed round in January. Prominent Saudi angel investors including Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas also participated.
The capital will be used to advance product development and grow Madeed’s network of clinical and laboratory partnerships, starting with a concentrated effort within the Saudi market. The funding is expected to accelerate the company’s growth and support a broader public launch of its services.
About Madeed
Founded in 2025 by Adam Bataineh, Madeed is a Saudi-based healthtech platform specializing in personalized preventive healthcare and longevity. It uses a proactive model that leverages advanced laboratory data and artificial intelligence to identify early disease risk indicators. The platform offers subscribers tailored health recommendations, customized health plans, and nutritional supplements to help them achieve a healthy lifestyle.
Source: Wamda
